北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Performance of an A1C and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, China
作者: Zhou, Xianghai3,4,5; Pang, Zengchang1; Gao, Weiguo2,3; Wang, Shaojie1; Zhang, Lei2,3; Ning, Feng3; Qiao, Qing2,3
刊名: DIABETES CARE
发表日期: 2010-03-01
DOI: 10.2337/dc09-1410
卷: 33, 期:3, 页:545-550
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Endocrinology & Metabolism
研究领域[WOS]: Endocrinology & Metabolism
关键词[WOS]: PLASMA-GLUCOSE ; CARDIOVASCULAR-DISEASE ; US POPULATION ; FOLLOW-UP ; HEMOGLOBIN ; RISK ; MORTALITY ; FRUCTOSAMINE ; ASSOCIATION ; PREVALENCE
英文摘要:

OBJECTIVE - The study′s goal was to evaluate the performance of A] C and lasting capillary blood glucose (FCG) tests as mass screening tools for diabetes and pre-diabetes, as determined by the standard oral glucose tolerance test (OGTT).

RESEARCH DESIGN AND METHODS - Data from 2,332 individuals aged 35-74 years who participated in a population-based cross-sectional diabetes survey in Qingdao, China, were analyzed. A 2-h 75-g OGTT was used to diagnose diabetes. The performance of A1C and FCG was evaluated against the results of the OGTTs by using receiver operating characteristic curve (ROC) analysis.

RESULTS - The prevalence of newly diagnosed diabetes and pre-diabetes (impaired fasting glucose and/or impaired glucose tolerance) was 11.9 and 29.5%, respectively. For subjects with newly diagnosed diabetes, the area under the ROC curve was 0.67 for A1C and 0.77 for FCG (P < 0.01) in men and 0.67 and 0.75 (P < 0.01) in women, whereas for pre-diabetes, these values were 0.47 and 0.64 (P < 0.001) in men and 0.51 and 0.65 (P < 0.001.) in women. At the optimal A1C cutoff point of >= 5.6% for newly diagnosed diabetes, sensitivities (specificities) were 64.4% (61.6%) for men and 62.3% (63.3%) for women.

CONCLUSIONS - As a screening tool for newly diagnosed diabetes and pre-diabetes, the FCG measurement performed better than A I C in this general Chinese population.

语种: 英语
所属项目编号: 118492
项目资助者: Finnish Academy ; Bayer HealthCare Company, Shanghai, China
WOS记录号: WOS:000275562700018
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/64730
Appears in Collections:北京大学第二临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Qingdao Ctr Dis Control & Prevent, Qingdao, Peoples R China
2.Univ Helsinki, Dept Publ Hlth, Helsinki, Finland
3.Peking Univ, Ctr Diabet, Beijing 100871, Peoples R China
4.Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland
5.Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China

Recommended Citation:
Zhou, Xianghai,Pang, Zengchang,Gao, Weiguo,et al. Performance of an A1C and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, China[J]. DIABETES CARE,2010,33(3):545-550.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhou, Xianghai]'s Articles
[Pang, Zengchang]'s Articles
[Gao, Weiguo]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhou, Xianghai]‘s Articles
[Pang, Zengchang]‘s Articles
[Gao, Weiguo]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace